Ripple CEO Brad Garlinghouse clarified that Ripple USD (RLUSD) is designed to compete with other stablecoins rather than XRP itself. He emphasized that RLUSD's use cases should run on the XRP Ledger (XRPL), distinguishing it from XRP's role. This statement came in response to a discussion about XRP's liquidity and potential as either a specialized institutional asset or a widely used everyday currency. Garlinghouse also noted that XRP may not suit every payment scenario, and Ripple might use fiat or RLUSD for certain transactions, highlighting a flexible approach to digital payments.
Ripple CEO Brad Garlinghouse's comments on RLUSD and XRP provide context for readers. For those following the cryptocurrency market, 42 out of 50 major cryptocurrencies on Pluang rose as of Nov 05, 2026 02:42 WIB. Notable movers include Ethereum Classic at Rp132.581 with a 3.73% increase and Bitcoin at Rp1.456.366.030 with a 3.36% rise.
The global e-learning market is projected to grow from $275.9 billion in 2026 to $506.6 billion by 2032, with a CAGR of 10.62% driven by rising internet connectivity, corporate upskilling demands, and government digital education initiatives. North A...
Goldman Sachs Group, Inc. disclosed that it briefly held a combined stake exceeding 3% in Ontex Group NV shares as of October 27, 2026, with 566,115 voting rights and 1,965,157 financial instruments. However, by October 28, 2026, their combined posit...
BNP Paribas announced its monthly declaration of voting rights and shares as of October 31, 2026. The bank reported a total of 1,101,600,607 shares and an equal number of voting rights. This update is part of regulatory compliance under French commer...
Ontex disclosed that Goldman Sachs Group, Inc. crossed the 3% ownership threshold in Ontex shares on October 27, 2026, holding a combined total of 3.07% including voting rights and financial instruments. However, the next day, October 28, 2026, Goldm...
Neion Bio has appointed John A. Maga, Ph.D., as Head of Biologics and CMC to lead the development of biologic medicines using its Raptor platform, which produces proteins in transgenic chicken eggs. Maga brings over 25 years of biopharmaceutical expe...
